Key result
Pharmacist-led transition of care linked to ~46% lower 90-day readmissions after ACS.
Why the study?
Existing literature evaluating pharmacist-driven transition of care initiatives targeting patients with acute coronary syndromes is limited.
Does a pharmacist-driven transition of care program reduce readmission rates in patients with acute coronary syndromes?
Cohort (n=300)
No
Does a pharmacist-driven transition of care program reduce readmission rates in patients with acute coronary syndromes?
Absolute Event Rate: 13.3% vs 24.7%
p-value: p=0.0124
Implementation of a pharmacist-driven transition of care program for ACS patients significantly reduces short-term all-cause and cardiovascular readmissions.
Authors
No takes yet. Share an insight, caveat, or question.
May support pharmacist-led ACS transitions of care; hypothesis-generating and requires randomized confirmation before practice change.
Gorman et al. (2018) conducted a cohort in Acute coronary syndromes (n=300). Pharmacist-driven transition of care (TOC) initiative vs. Historical cohort (no pharmacist TOC intervention) was evaluated on 90-day all-cause readmission rate (p=0.0124). A pharmacist-driven transition of care program for patients with acute coronary syndromes significantly reduced 90-day all-cause readmissions compared to historical controls (13.3% vs 24.7%, P=0.0124).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: